BHC:NYSE
Bausch Health Companies Inc
$6.42
arrow_upward
+1.34%(+0.085) 1D
$6.42
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 20, 4:00:07 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BHC...
Open
$6.42
High
$6.54
Low
$6.36
Mkt. cap
2.41B
Avg. vol.
1.95M
Volume
2.03M
52-wk high
$8.00
52-wk low
$4.33
EPS
-$2.96
Beta
0.37
Shares outstanding
373.99M
No. of employees
20K
Open
$6.42
High
$6.54
Low
$6.36
Mkt. cap
2.41B
Avg. vol.
1.95M
Volume
2.03M
52-wk high
$8.00
52-wk low
$4.33
EPS
-$2.96
Beta
0.37
Shares outstanding
373.99M
No. of employees
20K
News stories
From web sources and news partners
ad-hoc-news.de
·
3 hours ago
RBC keeps USD 9.00 target for Bausch Health stock
Stock Traders Daily
·
1 day ago
(BHC) Stock Market Analysis (BHC:CA)
Profile
Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20.3K
Founded1960
HeadquartersLaval, Quebec, Canada
SectorPharmaceutical industry
Websitebauschhealth.com